$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple
02:20pm, Wednesday, 22'nd Feb 2023
Dexcom stock slumped Wednesday on a report Apple is working to add a blood glucose monitor to its popular Apple Watch. The post Dexcom Slumps As A New Rival Reportedly Arrives On Scene: Apple appeared
Dexcom shares fall on news Apple is progressing on glucose tracking for watch
01:44pm, Wednesday, 22'nd Feb 2023
CNBC's Steve Kovach joins the 'Halftime Report' to report on Dexcom shares dropping on news that Apple is making progress on including a glucose tracking feature on the Apple Watch.
2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands
05:21am, Monday, 20'th Feb 2023
A poor performance from the broad market didn't stop these billionaire hedge fund managers from placing big bets on three supercharged growth stocks.
2 No-Brainer Growth Stocks to Buy Right Now
09:45am, Sunday, 19'th Feb 2023
Don't let these incredible businesses pass you by.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
08:25am, Sunday, 19'th Feb 2023
This healthcare space is bursting with opportunity for long-term investors.
Deere Leads 5 Stocks With Hot Products Near Buy Points
09:04am, Saturday, 18'th Feb 2023
Deere, fresh off Friday's strong earnings move, leads this weekend's watch list of 5 stocks near buy points. The post Deere Leads 5 Stocks With Hot Products Near Buy Points appeared first on Investor'
2 Growth Stocks That Could Help Make You a Fortune
08:53am, Monday, 13'th Feb 2023
These companies have what it takes to deliver outsized returns over the long haul.
Dexcom CEO on working with insurance companies
07:51pm, Friday, 10'th Feb 2023
Cramer spoke with Dexcom CEO Kevin Sayer on Friday.
DexCom (DXCM) Q4 Earnings Beat Estimates, Volumes Remain Strong
10:32am, Friday, 10'th Feb 2023
DexCom's (DXCM) fourth-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.
DexCom, Inc. (DXCM) Q4 2022 Earnings Call Transcript
09:31pm, Thursday, 09'th Feb 2023
DexCom, Inc. (NASDAQ:DXCM ) Q4 2022 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Sean Christensen - Vice President of Finance & Investor Relations Jereme Sylvain - Executi
DexCom (DXCM) Tops Q4 Earnings and Revenue Estimates
06:50pm, Thursday, 09'th Feb 2023
DexCom (DXCM) delivered earnings and revenue surprises of 30.77% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Dexcom Advances On Fourth-Quarter Beat, Reiterates Its 2023 Sales Expectations
04:13pm, Thursday, 09'th Feb 2023
Dexcom stock rose late Thursday after beating fourth-quarter expectations and reiterating its 2023 sales outlook. The post Dexcom Advances On Fourth-Quarter Beat, Reiterates Its 2023 Sales Expectation
Ranking The Diversified Healthcare Giants
10:53pm, Sunday, 22'nd Jan 2023
The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.
2 No-Brainer Growth Stocks to Buy Right Now
05:10am, Friday, 20'th Jan 2023
Don't overlook these growth plays.
The Top 7 “Millionaire-Maker” Long-Term Stocks for 2023
11:09am, Thursday, 19'th Jan 2023
Study after study shows that a long-term buy-and-hold investing strategy works best. A long-term investment is generally defined as any position in a stock that is held for a year or longer.
Sign In
Buy DXCM